Fingerprint Dive into the research topics where Endocrinology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Type 2 Diabetes Mellitus Medicine & Life Sciences
Insulin Medicine & Life Sciences
Vascular Calcification Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Hypoglycemia Medicine & Life Sciences
Glucose Medicine & Life Sciences
Medical problems Chemical Compounds
Hypoglycemic Agents Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Jessica D Abramowitz

Jessica D Abramowitz

Person: Academic

20062019
No photo of Marconi Abreu

Marconi Abreu

Person: Academic

20092019
No photo of Sadia Ali

Sadia Ali

Person: Academic

20142017

Research Output 1985 2019

Open Access
Patient Safety
Type 2 Diabetes Mellitus
Insulin
Hypoglycemia
Therapeutics

Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: A post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial

Leiter, L. A., Bain, S. C., Hramiak, I., Jódar, E., Madsbad, S., Gondolf, T., Hansen, T., Holst, I. & Lingvay, I., Jun 6 2019, In : Cardiovascular Diabetology. 18, 1, 73.

Research output: Contribution to journalArticle

Open Access
Risk Reduction Behavior
Type 2 Diabetes Mellitus
Stroke
Myocardial Infarction
Placebos

Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial

Blonde, L., Bailey, T. S., Chao, J., Dex, T. A., Frias, J. P., Meneghini, L. F., Roberts, M. & Aroda, V. R., Jan 1 2019, In : Advances in Therapy.

Research output: Contribution to journalArticle

Open Access
Type 2 Diabetes Mellitus
Glucose
Fasting
Hypoglycemia
Insulin